An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer

Oncogene

Volumn 33, Issue 49, 2014, Pages 5637-5648

  Sulahian, R ^a,b   Casey, F ^c   Shen, J ^c   Qian, Z R ^a,b   Shin, H ^a   Ogino, S ^a,b   Weir, B A ^a   Vazquez, F ^a   Liu, X S ^a   Hahn, W C ^a,b,d   Bass, A J ^a,b,d   Chan, V ^c   Shivdasani, R A ^a,b,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ChIP seq; GATA transcription factors; somatic copy number alterations; synexpression groups; transcriptional control of cancer

Indexed keywords

GATA4 PROTEIN, HUMAN; GATA6 PROTEIN, HUMAN; HISTONE; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6;

APOPTOSIS; BINDING SITE; CELL CYCLE; CELL LINEAGE; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE;

APOPTOSIS; BINDING SITES; CELL CYCLE; CELL LINE, TUMOR; CELL LINEAGE; CELL PROLIFERATION; EPIGENESIS, GENETIC; GATA4 TRANSCRIPTION FACTOR; GATA6 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84889008610     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.517     Document Type: Article

References (49)

1. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005; 436: 117-122.
2. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007; 450: 893-898.
3. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 2009; 41: 1238-1242.
4. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995; 9: 401-406.
5. Darnell Jr. JE. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002; 2: 740-749.
6. Redell MS, Tweardy DJ. Targeting transcription factors for cancer therapy. Curr Pharm Des 2005; 11: 2873-2887.
7. Dulak AM, Schumacher S, van Lieshout J, Imamura Y, Fox C, Shim B et al. Gastrointestinal adenocarcinomas of the esophagus, stomach and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res 2012; 72: 4383-4393.
8. Alvarez H, Opalinska J, Zhou L, Sohal D, Fazzari MJ, Yu Y et al. Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet 2011; 7: e1001356.
9. Lin L, Bass AJ, Lockwood WW, Wang Z, Silvers AL, Thomas DG et al. Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma. Proc Natl Acad Sci USA 2012; 109: 4251-4256.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
11. Matsuda A, Machii R. Trends in stomach cancer mortality rates in Japan, USA, UK, France and Korea based on the WHO mortality database. Jpn J Clin Oncol 2012; 42: 154.
12. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 1999; 85: 1894-1902.
13. Lennerz JK, Kwak EL, Ackerman A, Michael M, Fox SB, Bergethon K et al. MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. J Clin Oncol 2011; 29: 4803-4810.
14. Okines A, Cunningham D, Chau I. Targeting the human EGFR family in esophagogastric cancer. Nat Rev Clin Oncol 2011; 8: 492-503.
15. Laverriere AC, MacNeill C, Mueller C, Poelmann RE, Burch JB, Evans T. GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J Biol Chem 1994; 269: 23177-23184.
16. Fang R, Olds LC, Sibley E. Spatio-temporal patterns of intestine-specific transcription factor expression during postnatal mouse gut development. Gene Expr Patterns 2006; 6: 426-432.
17. Beuling E, Baffour-Awuah NY, Stapleton KA, Aronson BE, Noah TK, Shroyer NF et al. GATA factors regulate proliferation, differentiation, and gene expression in small intestine of mature mice. Gastroenterology 2011; 140: 1219-1229.
18. Verzi MP, Shin H, He HH, Sulahian R, Meyer CA, Montgomery RK et al. Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev Cell 2010; 19: 713-726.
19. Schmidt PH, Lee JR, Joshi V, Playford RJ, Poulsom R, Wright NA et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 1999; 79: 639-646.
20. Fu B, Luo M, Lakkur S, Lucito R, Iacobuzio-Donahue CA. Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma. Cancer Biol Ther 2008; 7: 1593-1601.
21. Kwei KA, Bashyam MD, Kao J, Ratheesh R, Reddy EC, Kim YH et al. Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. PLoS Genet 2008; 4: e1000081.
22. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 2007; 104: 20007-20012.
23. Holtzinger A, Evans T. Gata4 regulates the formation of multiple organs. Development 2005; 132: 4005-4014.
24. Zhao R, Watt AJ, Battle MA, Li J, Bondow BJ, Duncan SA. Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev Biol 2008; 317: 614-619.
25. Cheung HW, Cowley GS, Weir BA, Boehm JS, Rusin S, Scott JA et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci USA 2011; 108: 12372-12377.
26. Welch JJ, Watts JA, Vakoc CR, Yao Y, Wang H, Hardison RC et al. Global regulation of erythroid gene expression by transcription factor GATA-1. Blood 2004; 104: 3136-3147.
27. Yu M, Riva L, Xie H, Schindler Y, Moran TB, Cheng Y et al. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol Cell 2009; 36: 682-695.
28. Jang JH, Shin KH, Park JG. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Cancer Res 2001; 61: 3541-3543.
29. Kunii K, Davis L, Gorenstein J, Hatch H, Yashiro M, Di Bacco A et al. FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival. Cancer Res 2008; 68: 2340-2348.
30. Abdi H, Williams LJ. Principal component analysis. CompStat 2010; 2: 433-459.
31. Zeitlinger J, Zinzen RP, Stark A, Kellis M, Zhang H, Young RA et al. Whole-genome ChIP-chip analysis of Dorsal, Twist, and Snail suggests integration of diverse patterning processes in the Drosophila embryo. Genes Dev 2007; 21: 385-390.
32. Eeckhoute J, Lupien M, Meyer CA, Verzi MP, Shivdasani RA, Liu XS et al. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res 2009; 19: 372-380.
33. Tamura S, Wang XH, Maeda M, Futai M. Gastric DNA-binding proteins recognize upstream sequence motifs of parietal cell-specific genes. Proc Natl Acad Sci USA 1994; 91: 4609 1993;90:10876-80.
34. Gao X, Sedgwick T, Shi YB, Evans T. Distinct functions are implicated for the GATA- 4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation. Mol Cell Biol 1998; 18: 2901-2911.
35. Beck F, Chawengsaksophak K, Waring P, Playford RJ, Furness JB. Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc Natl Acad Sci USA 1999; 96: 7318-7323.
36. Verzi MP, Shin H, Ho LL, Liu XS, Shivdasani RA. Essential and redundant functions of caudal family proteins in activating adult intestinal genes. Mol Cell Biol 2011; 31: 2026-2039.
37. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 2003; 14: 3208-3215.
38. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-1007.
39. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010; 6: 25-36.
40. Heng JC, Feng B, Han J, Jiang J, Kraus P, Ng JH et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 2010; 6: 167-174.
41. Kageyama R, Ohtsuka T, Kobayashi T. The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development 2007; 134: 1243-1251.
42. Kim TH, Shivdasani RA. Notch signaling in stomach epithelial stem cell homeostasis. J Exp Med 2011; 208: 677-688.
43. Ross J, Mavoungou L, Bresnick EH, Milot E. GATA-1 utilizes Ikaros and polycomb repressive complex 2 to suppress Hes1 and to promote erythropoiesis. Mol Cell Biol 2012; 32: 3624-3638.
44. Guiu J, Shimizu R, D'Altri T, Fraser ST, Hatakeyama J, Bresnick EH et al. Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling. J Exp Med 2013; 210: 71-84.
45. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostat 2003; 4: 249-264.
46. Shechter D, Dormann HL, Allis CD, Hake SB. Extraction, purification and analysis of histones. Nat Protoc 2007; 2: 1445-1457.
47. Liu T, Ortiz JA, Taing L, Meyer CA, Lee B, Zhang Y et al. Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol 2011; 12: R83.
48. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G et al. A comprehensive survery of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutics targets. Gut. 2012; 61: 673-684.
49. Deng N, Goh LK, Wang H, Das K, Tao J, Tan IB et al. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 2012; 61: 673-684.